SARS-CoV-2 Inhibition by Sulfonated Compounds
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) depends on angiotensin converting enzyme 2 (ACE2) for cellular entry, but it might also rely on attachment receptors such as heparan sulfates. Several groups have recently demonstrated an affinity of the SARS-CoV2 spike protein for...
Main Authors: | Matteo Gasbarri, Philip V’kovski, Giulia Torriani, Volker Thiel, Francesco Stellacci, Caroline Tapparel, Valeria Cagno |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/8/12/1894 |
Similar Items
-
Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2
by: Valeria De Pasquale, et al.
Published: (2021-06-01) -
Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
by: Jingwen Yue, et al.
Published: (2021-06-01) -
Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry
by: Rahul K. Suryawanshi, et al.
Published: (2021-06-01) -
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
by: Valeria Cagno, et al.
Published: (2019-07-01) -
Viruses Like Sugars: How to Assess Glycan Involvement in Viral Attachment
by: Gregory Mathez, et al.
Published: (2021-06-01)